Browsing Tag
MiRus
2 posts
Boston Scientific (BSX) Q2 2026 beats estimates as MiRus TAVR investment reshapes strategy
Boston Scientific lifted FY 2026 guidance and disclosed a $1.5B MiRus TAVR bet, but BSX trades near 52-week lows as softer Q3 growth guidance stings.
July 29, 2026
MiRus earns NTAP approval for EUROPA cervical fusion system, expanding clinical and reimbursement footprint
MiRus receives CMS NTAP approval for its EUROPA Posterior Cervical Fusion System, boosting adoption and access for Medicare patients with spine disorders.
August 1, 2025